P1.07-024 ISEND May Predict Clinical Outcomes for Advanced NSCLC Patients on PD-1/PD-L1 Inhibitors but Not Chemotherapies or Targeted Kinase Inhibitors

著录项

• 来源
  《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第11期|共1页
• 作者

  W. Park; D. Kwon; A. Desai; V. Florou; D. Saravia; J. Warsch; Y.K. Chae; A. Ishkanian; M. Jahanzeb; R. Mudad; G. Lopes;

  展开▼
• 作者单位

  Hematology and Oncology University of Miami Sylvester Comprehensive Cancer Center;

  Department of Medicine Biostatistics and Bioinformatics University of Miami Sylvester;

  Hematology and Oncology University of Miami Sylvester Comprehensive Cancer Center;

  Hematology and Oncology University of Miami Sylvester Comprehensive Cancer Center;

  Internal Medicine University of Miami Miller School of Medicine;

  Radiology University of Miami Sylvester Comprehensive Cancer Center;

  Developmental Therapeutics Program of the Division of Hematology Oncology Robert H Lurie;

  Radiation Oncology University of Miami Sylvester Comprehensive Cancer Center;

  Medical Oncology University of Miami Sylvester Comprehensive Cancer Center;

  Sylvester Comprehensive Cancer Center University of Miami;

  Global Oncology Sylvester Comprehensive Cancer Center at the University of Miami;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词